Investors Investors Lobby Company Profile Company Presentation Immediate Reports Investors News Financial Reports From The Press Media Stock Chart FAQ Contact IR Investors News Together completes control of the value chain with the receipt of IMC-GMP certification for its facility: The facility will save the company packaging expenses which have to date been paid to a third party for the production and packaging of medical cannabis products, and will also provide production and packaging services to other medical cannabis companies. Upon the facility’s certification, Together now controls all stages of production – from propagation and growing, through production of the products to sales through collaboration with pharmacies nationwide 06/06/2021 Together Pharma releases its financial statements for the first quarter of 2021: Revenue in the quarter of ILS 3.2 million – up 130% Transition to gross quarterly profit of ILS 1.7 million, at 54% Quarterly operating profit of ILS 2.1 million, at 60% 01/06/2021 Medical cannabis produced by Together in Israel used to make products which are marketed for the first time in Europe, in the context of a collaboration with Panaxia 01/04/2021 From The Press Benzinga: Israeli cannabis company Together Pharma, began the export of medical cannabis from its 30-dunam, GACP-certified facility in Uganda to Israel 19/04/2020 Globes: Together wins medical cannabis export permit from Uganda 29/01/2020 Immediate Reports Subsidiary received the license required to start production operations at the Company’s plant 16/06/2021 IMC-GMP standard certification received for the company’s plant, and control of the value chain completed 06/06/2021 stock Tel Aviv: TGTR 153 Price -0.58% Change percentage -0.9 Change 157 152.3 Last Update:17/06/2021 at:17:11 Presentations Company Presentation January 2020 Financial Reports 1st Quarter 2021 31/05/2021 Annual Report 2020 24/03/2021 Mail Alert Subscribe to Receive Notifications by Email First Name Last Name Email Send
Together completes control of the value chain with the receipt of IMC-GMP certification for its facility: The facility will save the company packaging expenses which have to date been paid to a third party for the production and packaging of medical cannabis products, and will also provide production and packaging services to other medical cannabis companies. Upon the facility’s certification, Together now controls all stages of production – from propagation and growing, through production of the products to sales through collaboration with pharmacies nationwide 06/06/2021
Together Pharma releases its financial statements for the first quarter of 2021: Revenue in the quarter of ILS 3.2 million – up 130% Transition to gross quarterly profit of ILS 1.7 million, at 54% Quarterly operating profit of ILS 2.1 million, at 60% 01/06/2021
Medical cannabis produced by Together in Israel used to make products which are marketed for the first time in Europe, in the context of a collaboration with Panaxia 01/04/2021
Benzinga: Israeli cannabis company Together Pharma, began the export of medical cannabis from its 30-dunam, GACP-certified facility in Uganda to Israel 19/04/2020
Subsidiary received the license required to start production operations at the Company’s plant 16/06/2021
IMC-GMP standard certification received for the company’s plant, and control of the value chain completed 06/06/2021
